OKUWA, Last Fiscal Year Net Income Revised Downward to a Loss
8217 OKUWA CO., LTD. 【J-GAAP】
Guidance Update ReportOKUWA CO., LTD. <8217> [TSE Prime] announced a performance revision after the market closed on March 25th (15:30). The consolidated net income/loss for the fiscal year ending February 2025 has been revised downward from an expected profit of 0.55 billion yen to a loss of 2.38 billion yen (compared to a profit of 1 billion yen in the previous period), turning to a loss outlook.
Based on the downwardly revised full-year plan announced by the company, our calculation indicates that the September to February period (2H) consolidated net income/loss has been revised downward from an expected profit of 0.46 billion yen to a loss of 2.46 billion yen (compared to a profit of 0.6 billion yen in the same period of the previous year), turning to a loss outlook.
Kabutan News
Guidance Update
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep - Feb, 2024 Prev | 131,442M | 2,204M | 2,187M | 463M | 11.1 | 13 | Oct 1, 2024 | J-GAAP |
| Sep - Feb, 2024 New | 127,592M | 1,074M | 1,127M | -2,467M | -57.9 | 13 | Mar 25, 2025 | J-GAAP |
| Revision Rate | -2.9% | -51.3% | -48.5% | － | － |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Feb, 2025 Prev | 254,000M | 2,450M | 2,500M | 550M | 13.2 | 26 | Sep 26, 2024 | J-GAAP |
| Feb, 2025 New | 250,150M | 1,320M | 1,440M | -2,380M | -55.9 | 26 | Mar 25, 2025 | J-GAAP |
| Revision Rate | -1.5% | -46.1% | -42.4% | － | － |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
125,858M | 2,182M | 2,279M | 601M | 13.7 | 13 | Apr 2, 2024 | J-GAAP |
|
Guidance
Sep - Feb, 2024
|
127,592M | 1,074M | 1,127M | -2,467M | -57.9 | 13 | Mar 25, 2025 | J-GAAP |
| YoY | +1.4% | -50.8% | -50.5% | － | － |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
246,877M | 2,927M | 3,148M | 928M | 21.2 | 26 | Apr 3, 2023 | J-GAAP |
|
|
247,378M | 2,888M | 3,098M | 1,000M | 22.8 | 26 | Apr 2, 2024 | J-GAAP |
|
Guidance
Feb, 2025
|
250,150M | 1,320M | 1,440M | -2,380M | -55.9 | 26 | Mar 25, 2025 | J-GAAP |
| YoY | +1.1% | -54.3% | -53.5% | － | － |
Related Articles
-
OPTOELECTRONICS, Dec-Feb (1Q) Ordinary Profit Loss Narrows
Tue Mar 25, 2025 3:45 pm JST Earnings -
New Japan Chemical, The Current Fiscal Year Net Income Revised Downward by 64%
Tue Mar 25, 2025 3:40 pm JST Revision -
SD ENTERTAINMENT, Decides to Continue No Dividend Policy
Tue Mar 25, 2025 3:30 pm JST Revision -
Osaki Electric, Current Fiscal Year Dividend Revised Upward by 2 yen
Tue Mar 25, 2025 3:35 pm JST Revision -
NIPPON SANSO, The Current Fiscal Year Net Income Revised Downward to an Unexpected 9% Decrease
Tue Mar 25, 2025 3:30 pm JST Revision -
Imperial Hotel, The Current Fiscal Year Net Income Revised Upward by 39%
Tue Mar 25, 2025 2:00 pm JST Revision -
WAKAMOTO PHARMA, The Undetermined Dividend Set at 3 yen
Tue Mar 25, 2025 12:30 pm JST Revision -
Pharmarise Holdings, Jun-Feb (Cumulative 3Q) Ordinary Profit Turns to Loss, Dec-Feb Ordinary Profit Turns to Loss
Tue Mar 25, 2025 12:00 pm JST Earnings -
The Nikkei 225 recovered to 38,000 yen level for the first time in 6 days
Tue Mar 25, 2025 9:03 am JST Market -
Nikkei 225 open on the 25th = 344 yen higher, 37,953 yen
Tue Mar 25, 2025 9:02 am JST Market